Internal medicine, Gastroenterology, Surgery, Helicobacter pylori and Inflammatory bowel disease are his primary areas of study. His study in Ulcerative colitis, Clarithromycin, Adverse effect, Crohn's disease and Omeprazole is done as part of Internal medicine. His Gastroenterology research is multidisciplinary, incorporating perspectives in Odds ratio, Antibacterial agent, Disease and Meta-analysis.
His Surgery research includes themes of Clinical trial, Pharmacotherapy, Rifabutin and Levofloxacin. His Helicobacter pylori research includes elements of Regimen, Antibiotics, MEDLINE and Proton-pump inhibitor. The Inflammatory bowel disease study combines topics in areas such as Pregnancy, Anemia, Immunology, Azathioprine and Prospective cohort study.
His primary areas of investigation include Internal medicine, Gastroenterology, Helicobacter pylori, Inflammatory bowel disease and Ulcerative colitis. His research in Internal medicine focuses on subjects like Surgery, which are connected to Adverse effect. He interconnects Prospective cohort study and Azathioprine in the investigation of issues within Gastroenterology.
His Helicobacter pylori research is multidisciplinary, incorporating perspectives in Regimen, Levofloxacin, Proton-pump inhibitor and Metronidazole. His research in Inflammatory bowel disease intersects with topics in Tumor necrosis factor alpha and Immunology. His study looks at the intersection of Ulcerative colitis and topics like Infliximab with Adalimumab.
The scientist’s investigation covers issues in Internal medicine, Inflammatory bowel disease, Ulcerative colitis, Gastroenterology and Crohn's disease. When carried out as part of a general Internal medicine research project, his work on Helicobacter pylori, Adverse effect, Infliximab and Cohort is frequently linked to work in In patient, therefore connecting diverse disciplines of study. He combines subjects such as Regimen, Metronidazole and Levofloxacin with his study of Helicobacter pylori.
His research on Inflammatory bowel disease also deals with topics like
Immunology which intersects with area such as Intestinal mucosa,
Intensive care medicine and related MEDLINE,
Confidence interval that intertwine with fields like Odds ratio. His Ulcerative colitis study integrates concerns from other disciplines, such as Colitis, Tofacitinib and Discontinuation. His research on Gastroenterology also deals with topics like
Prospective cohort study that connect with fields like Interquartile range,
Retrospective cohort study which connect with Case-control study.
Javier P. Gisbert spends much of his time researching Internal medicine, Inflammatory bowel disease, Ulcerative colitis, Gastroenterology and Crohn's disease. His work in Adverse effect, Helicobacter pylori, Cohort, Cohort study and Meta-analysis are all subfields of Internal medicine research. His Inflammatory bowel disease research incorporates themes from Retrospective cohort study, Immunology, Immune tolerance, Immune system and Hazard ratio.
His Ulcerative colitis research is multidisciplinary, incorporating elements of Discontinuation and Infliximab. His work blends Gastroenterology and In patient studies together. His work in Crohn's disease covers topics such as Confidence interval which are related to areas like Mixed anxiety-depressive disorder, Depression and Quality of life.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
Peter Malfertheiner;Francis Megraud;John Atherton;Anthony T R Axon.
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
P. Malfertheiner;F. Mégraud;C. O'Morain;Javier Gisbert.
Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease : A Review
Javier P Gisbert;Julián Panés.
The American Journal of Gastroenterology (2009)
Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease
J. Panés;R. Bouzas;M. Chaparro;V. García-Sánchez.
Alimentary Pharmacology & Therapeutics (2011)
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults
Carlo A. Fallone;Naoki Chiba;Naoki Chiba;Sander Veldhuyzen van Zanten;Lori Fischbach.
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial
David Laharie;Arnaud Bourreille;Julien Branche;Matthieu Allez.
The Lancet (2012)
Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure.
J. P. Gisbert;F. Morena.
Alimentary Pharmacology & Therapeutics (2006)
Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection -- a critical review.
J. P. Gisbert;J. M. Pajares.
Alimentary Pharmacology & Therapeutics (2004)
Addition of a second endoscopic treatment following epinephrine injection improves outcome in high-risk bleeding ulcers.
Xavier Calvet;Mercedes Vergara;Enric Brullet;Javier P. Gisbert.
Meta‐analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users
M Vergara;M Catalan;JP Gisbert;X Calvet.
Alimentary Pharmacology & Therapeutics (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: